This cohort study estimates lifetime incidence of breast and ovarian cancer among females undergoing BRCA1 or BRCA2 testing across all result categories and evaluates the modifying association of family history.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Projected Benefit of Bilateral Salpingo-Oophorectomy by Age in BRCA Carriers | 0 | 11.34 | 23-09-2026 |
| 2 | Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained Individuals | 0 | 6.31 | 01-07-2026 |
| 3 | Genome analysis uncovers candidate genes for hereditary breast and ovarian cancer | 0 | 10.43 | 14-08-2026 |
| 4 | Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer | 0 | 7.57 | 01-07-2026 |
| 5 | Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer | 0 | 7.64 | 01-10-2024 |
| 6 | Medically Assisted Reproduction and Hormone-Related Cancers | 0 | 5 | 13-07-2026 |
| 7 | Racial Differences in Evaluation in Suspected Cases of Endometrial Neoplasia | 0 | 5.76 | 04-08-2026 |
| 8 | Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors | 0 | 7 | 25-06-2026 |
| 9 | Circulating Tumor DNA in Early Breast Cancer | 0 | 9.02 | 01-07-2026 |